Skip to main contentSkip to main content
info@smcsalud.org
Educational Guide

Diabetic Foot Second Opinion

When you've received a treatment plan or an amputation recommendation and want another perspective, a second opinion can provide clarity. This guide explains what a second opinion involves and how Cuba's multidisciplinary evaluation program works. Information only, not medical advice.

Heberprot-P therapy For US families & caregiversNot available in the US
38.4M
Americans with diabetes (2024)
15%
of diabetics develop foot ulcers
$409B
Annual US diabetes care cost
4–8 wks
Cuba program cycles (individualized)

Educational Resource — Not Medical Advice

The information on this page is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your qualified healthcare provider before making decisions about treatment options.

We do not target, identify, or retarget individuals based on health conditions. This content is intended for families and caregivers seeking information about international treatment options, and is discoverable through organic search.

Why Seek a Second Opinion

When Another Perspective Helps

Seeking a second opinion is a common and responsible step, especially when facing a serious treatment decision. A fresh evaluation by a different team can confirm, refine, or offer alternatives to your current treatment plan.

Amputation Recommendation

If amputation has been recommended, a second opinion can determine whether limb-preserving alternatives exist — including intensive wound care, revascularization, and advanced therapies.

Ulcer Not Healing

If your ulcer hasn't healed despite weeks of care, a new evaluation team may identify barriers that were missed and suggest different treatment approaches.

Treatment Plan Questions

If you're uncertain about your current treatment plan, a second opinion can confirm whether you're receiving the most appropriate care or whether additional options exist.

Access to Different Therapies

Cuba's program offers Heberprot-P intra-lesional therapy, which is not available in the United States. A second opinion can help determine whether this may be relevant to your case.

How It Works

Cuba's Second-Opinion Evaluation Process

Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. The process is thorough and individualized — not a one-size-fits-all assessment.

Medical Records Review

Submit your medical records, imaging, wound photos, and current treatment plan for review by our Cuban specialist team.

Multidisciplinary Assessment

Endocrinologists, vascular surgeons, podiatrists, and wound care specialists jointly review your case and discuss findings.

Individualized Recommendation

You receive a written assessment of whether Cuba's program may be appropriate for your case, and what a personalized program would involve.

No Obligation

The second-opinion evaluation is provided at no cost and with no obligation to travel. You decide whether to proceed.

Coordination with Your US Physician

If you proceed, we coordinate with your US healthcare provider to ensure continuity of care before and after any international treatment.

Transparent Communication

If our team determines that Cuba's program is not appropriate for your case, we will tell you honestly and recommend you continue with your current care.

Cuba's Approach

The Cuban Diabetic Foot Program

Cuba has developed a comprehensive diabetic foot treatment program centered on Heberprot-P — a recombinant human epidermal growth factor (rh-EGF) administered by intra-lesional injection directly into the wound. This therapy is combined with intensive, multidisciplinary wound care. Our team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Heberprot-P is not available in the United States.

  • Heberprot-P intra-lesional rh-EGF therapy — a Cuban biotechnology innovation
  • Intensive daily wound care by specialist teams
  • Multidisciplinary team: endocrinologists, podiatrists, vascular surgeons, wound care nurses
  • 4–8 week individualized program cycles with continuous monitoring
  • Limb preservation focus — our team evaluates each patient individually
  • Coordinated aftercare and handover to your US physician

Heberprot-P®

Cuban biotechnology

Recombinant human epidermal growth factor (rh-EGF) developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB), administered by intra-lesional injection directly into diabetic foot wounds to stimulate healing.

4–8 Week Cycles

Multidisciplinary Team

Explore More

Diabetic Foot Care Resources

Explore our full range of educational diabetic foot care resources for US families and caregivers.

Your Journey to Cuba

From First Inquiry to Safe Return Home

01

Contact Us

Share your medical information and wound history through our inquiry form.

02

Free Evaluation

Our wound care team reviews your US records and designs a personalized plan.

03

Travel Coordination

We assist with e-Visa, flights, and accommodation in Cuba.

04

Treatment

Receive intensive wound care with Heberprot-P therapy and continuous support.

05

Aftercare

Coordinated handover to your US physician with a monitoring plan.

Frequently Asked Questions

Your Questions Answered

Submit Your Medical Records for a Diabetic Foot Evaluation

Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Share your medical records to receive a personalized assessment — often within 24–48 hours. No obligation, no travel required to get started.